These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2428128)

  • 1. The HLA-DP polymorphism in Denmark investigated by local and international PLT reagents. Definition of two "new" DP antigens.
    Odum N; Hartzman R; Jakobsen BK; Morling N; Platz P; Robbins FM; Ryder LP; Svejgaard A
    Tissue Antigens; 1986 Aug; 28(2):105-18. PubMed ID: 2428128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA-DPw antigens in Danes and Eskimos as determined by local bulk PTL-reagents.
    Petersen CM; Møller BK; Lamm LU
    Tissue Antigens; 1987 Nov; 30(5):217-28. PubMed ID: 3438908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A "new" supertypic HLA-DP related determinant detected by primed lymphocyte typing (PLT).
    Odum N; Hofmann B; Hyldig-Nielsen JJ; Jakobsen BK; Morling N; Platz P; Ryder LP; Svejgaard A
    Tissue Antigens; 1987 Feb; 29(2):101-9. PubMed ID: 2440144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An HLA-DR/DP recombinant family involving DPw6. Evidence for cross-reactivity between DPw6 and GNN2B.
    Odum N; Hartzman R; Jakobsen BK; Morling N; Platz P; Robbins FM; Ryder LP; Shaw S; Svejgaard A
    Tissue Antigens; 1986 Jan; 27(1):44-52. PubMed ID: 3082036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased frequency of HLA-DPw2 in pauciarticular onset juvenile chronic arthritis.
    Odum N; Morling N; Friis J; Heilmann C; Hyldig-Nielsen JJ; Jakobsen BK; Pedersen FK; Platz P; Ryder LP; Svejgaard A
    Tissue Antigens; 1986 Oct; 28(4):245-50. PubMed ID: 3492783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-DP antigens in patients with alopecia areata.
    Odum N; Morling N; Georgsen J; Jakobsen BK; Frentz G; Jensen GF; Fugger L; Svejgaard A
    Tissue Antigens; 1990 Mar; 35(3):114-7. PubMed ID: 2375044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA-DP antigens and HTLV-1 antibody status among Japanese with multiple sclerosis: evidence for an increased frequency of HLA-DPw4.
    Odum N; Saida T; Ohta M; Svejgaard A
    J Immunogenet; 1989 Dec; 16(6):467-73. PubMed ID: 2641759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recognition of DP determinants with typing reagents prepared with lymphocytes from Dutch unrelated individuals.
    Termijtelen A; Naipal-van den Berge S; Suwandi-Thung L; van Rood JJ
    Tissue Antigens; 1985 Oct; 26(4):234-42. PubMed ID: 3865456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular analysis of HLA-DP specificities HLA-DPw1, -DPw2 and -DPw4: DP beta chain heterogeneity correlates with PLT subtyping.
    Baas EJ; Bontrop RE; Otting N; Giphart MJ
    Tissue Antigens; 1988 Jan; 31(1):5-13. PubMed ID: 2829386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serological detection and molecular localization of allelic HLA-DP supertypic epitopes.
    Colonna M; Tanigaki N; Tosi R; Ferrara GB
    Eur J Immunol; 1989 Mar; 19(3):433-40. PubMed ID: 2468502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Southern blot analysis of HLA-DP gene polymorphisms in Caucasoid rheumatoid arthritis (RA) patients and controls.
    Stephens HA; Vaughan RW; Sakkas LI; Welsh KI; Panayi GS
    Immunogenetics; 1989; 30(3):149-55. PubMed ID: 2476386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of HLA-DP in HLA-DR/GLO recombinant families and in the population of south-western France.
    Thomsen M; Essaket S; Cambon-Thomsen A; Robbins FM; Hartzman RJ; Arnaud J; Ohayon E
    Tissue Antigens; 1990 Sep; 36(3):116-21. PubMed ID: 2278045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A "new" primed lymphocyte typing (PLT) defined DP-antigen associated with a private HLA--DR antigen.
    Morling N; Jakobsen BK; Platz P; Ryder LP; Svejgaard A; Thomsen M
    Tissue Antigens; 1980 Jul; 16(1):95-104. PubMed ID: 6162231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clonal analysis of HLA-DPw1 (SB1) associated allodeterminants: recognition of novel epitopes and evidence for quantitative variation in class II antigen expression.
    Eckels DD; Johnson AH; Hartzman RJ; Dacek D
    Hum Immunol; 1986 Feb; 15(2):234-50. PubMed ID: 2419289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intra HLA-D/DR region recombinant detected by primed lymphocyte typing (PLT).
    Jakobsen BK; Kristensen T; Lamm LU; Morling N; Bruun-Petersen G; Platz P; Ryder LP; Svejgaard A
    Tissue Antigens; 1983 Aug; 22(2):123-33. PubMed ID: 6578608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new HLA-DP (SB) specificity (Cp63) defined in Japanese and Caucasian cell populations by cloned PLT cells.
    Nose Y; Nakatsuji T; Tsuji K; Reinsmoen NL
    Hum Immunol; 1985 Jul; 13(3):145-9. PubMed ID: 3859482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between HLA-D/DR associated primed lymphocyte typing (PLT) defined DP-antigens, HLA-D and HLA-DR antigens.
    Morling N; Jakobsen BK; Platz P; Ryder LP; Svejgaard A; Thomsen M
    Tissue Antigens; 1981; 17(4):421-7. PubMed ID: 7036403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Typing for HLA-D/DR associated DP-antigens with the primed lymphocyte typing (PLT) technique.
    Morling N; Jakobsen BK; Platz P; Ryder LP; Svejgaard A; Thomsen M
    Tissue Antigens; 1980 May; 15(5):471-82. PubMed ID: 6449760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations in HLA-DP and HLA-DQ antigen frequency in patients with dermatitis herpetiformis.
    Hall RP; Sanders ME; Duquesnoy RJ; Katz SI; Shaw S
    J Invest Dermatol; 1989 Oct; 93(4):501-5. PubMed ID: 2570807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal antibodies to HLA-DP-transfected mouse L cells.
    Heyes J; Austin P; Bodmer J; Bodmer W; Madrigal A; Mazzilli MC; Trowsdale J
    Proc Natl Acad Sci U S A; 1986 May; 83(10):3417-21. PubMed ID: 3517859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.